Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients-Reference-Cited by-同舟云学术

Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients

Published:2015-08-14 Issue:10 Volume:52 Page:699-705
ISSN:0022-2593
Container-title:Journal of Medical Genetics
language:en
Short-container-title:J Med Genet

Author:

Hexter Adam,Jones Adrian,Joe Harry,Heap Laura,Smith Miriam J,Wallace Andrew J,Halliday Dorothy,Parry Allyson,Taylor Amy,Raymond Lucy,Shaw Adam,Afridi Shazia,Obholzer Rupert,Axon Patrick,King Andrew T,Friedman Jan M,Evans D Gareth R,

Publisher

BMJ

Subject

Genetics(clinical),Genetics

Reference46 articles.

1. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service;Evans;Am J Med Genet A,2010

2. Neurofibromatosis 2;Evans,1993–2015

3. Molecular insights into NF2/Merlin tumor suppressor function;Cooper;FEBS Lett,2014

4. Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature;Vranceanu;J Neurooncol,2013

5. A clinical study of type 2 neurofibromatosis;Evans;Q J Med,1992

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Death in a bathtub of an adolescent with neurofibromatosis type 2 exhibiting meningioangiomatosis with white matter involvement;Forensic Science, Medicine and Pathology;2024-08-24

2. Historical Development of Diagnostic Criteria for NF2-related Schwannomatosis;Neurologia medico-chirurgica;2024-08-15

3. Brigatinib in NF2 -Related Schwannomatosis with Progressive Tumors;New England Journal of Medicine;2024-06-27

5. Long-term outcomes of stereotactic radiosurgery for intracranial schwannoma in neurofibromatosis type 2: a genetic analysis perspective;Journal of Neuro-Oncology;2023-12-27